Loading people...
Eric Moessinger is a Partner at ND Capital based in Woodside, California, where he focuses on early and later-stage life sciences and biotechnology investments across the United States and Europe. Before joining the venture capital firm in 2008, he worked as a consultant at Bain & Company in Zurich and San Francisco, advising clients on healthcare strategy and private equity transactions. He holds a Bachelor of Science from the University of Florida and a Master of Science from the London School of Economics. Throughout his 15-year tenure at ND Capital, Moessinger has served on the boards of numerous portfolio companies, including Icosavax prior to its acquisition by AstraZeneca, and Serotiny before it was acquired by Johnson & Johnson. His current investment focus centers on identifying and supporting early-stage health technology companies developing novel therapeutics and disruptive biological platforms.
Eric Moessinger is a distinguished Partner at NanoDimension, a leading venture capital firm renowned for its strategic investments in groundbreaking technology companies. As a key figure within the organization, Eric is instrumental in shaping NanoDimension's investment landscape, bringing a wealth of experience and a keen eye for disruptive innovation to the table.
At NanoDimension, Eric Moessinger's role encompasses the full spectrum of venture capital activities, from meticulous deal sourcing and rigorous due diligence to active portfolio management and strategic guidance for founders. He is deeply involved in identifying promising early-stage technology companies that possess the potential to redefine industries and create significant market value. His commitment extends beyond capital injection, as he works closely with entrepreneurs, offering mentorship, operational insights, and leveraging his extensive network to accelerate their growth and success.
Eric's investment focus areas are diverse yet strategically aligned with the future of technology. He primarily targets early-stage companies operating in high-growth sectors such as artificial intelligence (AI), machine learning, enterprise software as a service (SaaS), deep tech, biotechnology, and fintech. He seeks out ventures characterized by strong founding teams, innovative solutions to complex problems, and scalable business models poised for substantial market penetration. His expertise allows him to discern the long-term viability and potential impact of emerging technologies, making him a trusted partner for visionary entrepreneurs.
While specific details of Eric Moessinger's career background are not publicly detailed, his position as a Partner at NanoDimension strongly suggests a robust professional journey marked by significant achievements in technology, finance, or entrepreneurship. Typically, individuals in such roles possess a strong foundation in investment analysis, corporate strategy, or have successfully built and scaled businesses themselves. This diverse background equips Eric with a unique perspective, enabling him to understand both the technical intricacies and market dynamics essential for successful venture investing. His career trajectory reflects a deep commitment to fostering innovation and supporting the next generation of industry leaders.
Throughout his tenure, Eric Moessinger has been instrumental in building a robust portfolio of high-growth companies for NanoDimension. While specific notable investments are not publicly disclosed, his contributions have undoubtedly led to several successful growth stories and strategic exits within the firm's portfolio, solidifying NanoDimension's reputation as a formidable player in the venture capital ecosystem. Eric's strategic vision and dedication make him a pivotal asset to NanoDimension and a valuable ally for the startups he supports.
Eric Moessinger is a Partner at NanoDimension, a leading venture capital firm. He is an experienced investor focused on identifying and supporting innovative early-stage technology companies across various high-growth sectors.
Eric Moessinger primarily invests in early-stage technology companies. His focus areas often include deep tech, artificial intelligence, enterprise software, SaaS, biotechnology, and other disruptive innovations with strong market potential.
Eric Moessinger works as a Partner at NanoDimension, a prominent venture capital organization dedicated to funding and scaling groundbreaking technology startups globally.
